Delivery Order SPE2DB25D9768-SPE2DB25FTTTM
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the vendor's Park Ridge facility and represents a single purchase under the...
- The Defense Logistics Agency awarded a $41,661.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation to supply this contraceptive implant device. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $12,498.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a $7,811.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a $14,008.45 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on August 19, 2025, with an ultimate completion date of September 10, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. No set-aside designation was applied to this award, allowing the company to compete directly in the open federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a supply of contraceptive medical devices to support Department of Defense healthcare requirements. The work will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a hormonal contraceptive implant device. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. This delivery order does not include a set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 19, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- SPE2DB25D9768Indefinite Delivery Contract
- SPE2DB25D9768-SPE2DB25FTTTMDelivery Order
The Defense Logistics Agency awarded a $15,623.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 2, 2025. This award was issued without a set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA, valued at approximately $500 million and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities. Mirena is a prescription contraceptive implant device widely used in federal healthcare systems. As a strategic supplier within the Department of Defense pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in competing for delivery orders covering diverse medical products ranging from specialty pharmaceuticals to biologics and over-the-counter medications. The company's established presence as a federal contractor since 2001 and its registration in the System for Award Management reflects its reliability in fulfilling critical pharmaceutical distribution requirements for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 9/11/25 |